Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  18F-fluoromethylcholine
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-8 of 8 for your search:
Start Over
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
Phase: Phase III
Type: Diagnostic
Status: Approved-not yet active
Age: 20 to 80
Sponsor: Other
Protocol IDs: 201111019MIB, NCT02074202
Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer
Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: RA-2008-069, R21CA139687, NCT00928252
Genomic and Imaging Study for Patients Undergoing Surgery for Liver Cancer
Phase: Phase II, Phase I
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RA-2011-025, R01CA161209, NCT01395030
PET Imaging of High-grade Glioma Using 18F-fluoromethylcholine: a Tool for the Early Detection of Tumour Recurrence After Combined Radiochemotherapy?
Phase: Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008/085, NCT00628940
Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)
Phase: Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010/115, NCT01116804
Multimodal Diagnostic Assessment of Cerebral Gliomas With FET & FCH PET/CT, and Magnetic Resonance Imaging/Spectroscopy
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 196/08, Swissmedic 2009DR3123, NCT00939315
The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 35 to 90
Sponsor: Other
Protocol IDs: 200706006M, NCT01089881
18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: 13-199, NCT02037945
Start Over